Page 47 - ITPS-7-2

INNOSC Theranostics and
Pharmacological Sciences Mitochondria and aging

257. Sarvari P, Sarvari P. Advances in nanoparticle-based 268. Cheng G, Zielonka J, Dranka BP, et al. Mitochondria-
drug delivery in cancer treatment. Glob Transl Med. targeted drugs synergize with 2-deoxyglucose to trigger
2023;2(2):0394. breast cancer cell death. Cancer Res. 2012;72(10):2634-2644.
doi: 10.36922/gtm.0394 doi: 10.1158/0008-5472.can-11-3928
258. Sarvari P, Sarvari P, Ramírez-Díaz I, Mahjoubi F, Rubio K. 269. Zhang D, Wen L, Huang R, Wang H, Hu X, Xing D.
Advances of epigenetic biomarkers and epigenome Mitochondrial specific photodynamic therapy by rare-
editing for early diagnosis in breast cancer. Int J Mol Sci. earth nanoparticles mediated near-infrared graphene
2022;23(17):9521. quantum dots. Biomaterials. 2018;153:14-26.
doi: 10.3390/ijms23179521 doi: 10.1016/j.biomaterials.2017.10.034
259. Kalyane D, Raval N, Maheshwari R, Tambe V, Kalia K, 270. Cheng X, Feng D, Lv J, et al. Application prospects of
Tekade RK. Employment of enhanced permeability and triphenylphosphine-based mitochondria-targeted cancer
retention effect (EPR): Nanoparticle-based precision tools therapy. Cancers (Basel). 2023;15(3):666.
for targeting of therapeutic and diagnostic agent in cancer. doi: 10.3390/cancers15030666
Mater Sci Eng C Mater Biol Appl. 2019;98:1252-1276.
271. Dong L, Gopalan V, Holland O, Neuzil J. Mitocans revisited:
doi: 10.1016/j.msec.2019.01.066 Mitochondrial targeting as efficient anti-cancer therapy. Int
260. Zhang L, Chan JM, Gu FX, et al. Self-assembled lipid J Mol Sci. 2020;21(21):7941.
polymer hybrid nanoparticles: A robust drug delivery doi: 10.3390/ijms21217941
platform. ACS Nano. 2008;2(8):1696-1702.
272. Cheng G, Zielonka J, McAllister DM, et al. Mitochondria-
doi: 10.1021/nn800275r targeted vitamin E analogs inhibit breast cancer cell
261. Porporato PE, Filigheddu N, Pedro JMBS, Kroemer G, energy metabolism and promote cell death. BMC Cancer.
Galluzzi L. Mitochondrial metabolism and cancer. Cell Res. 2013;13(1):285.
2018;28(3):265-280. doi: 10.1186/1471-2407-13-285
doi: 10.1038/cr.2017.155 273. Battogtokh G, Choi YS, Kang DS, et al. Mitochondria-
262. Pandey S, Nandi A, Basu S, Ballav N. Inducing endoplasmic targeting drug conjugates for cytotoxic, anti-oxidizing
reticulum stress in cancer cells using graphene oxide-based and sensing purposes: Current strategies and future
nanoparticles. Nanoscale Adv. 2020;2(10):4887-4894. perspectives. Acta Pharm Sin B. 2018;8(6):862-880.
doi: 10.1039/d0na00338g doi: 10.1016/j.apsb.2018.05.006
263. Bonam SR, Wang F, Muller S. Lysosomes as a therapeutic 274. Iacopetta D, Ceramella J, Rosano C, et al. N-Heterocyclic
target. Nat Rev Drug Discov. 2019;18(12):923-948. carbene-gold (I) complexes targeting actin polymerization.
Appl Sci. 2021;11(12):5626.
doi: 10.1038/s41573-019-0036-1
doi: 10.3390/app11125626
264. Tabish TA, Hamblin MR. Mitochondria-targeted
nanoparticles (mitoNANO): An emerging therapeutic 275. Odyniec ML, Han HH, Gardiner JE, et al. Peroxynitrite
shortcut for cancer. Biomater Biosyst. 2021;3:100023. activated drug conjugate systems based on a coumarin
scaffold toward the application of theranostics. Front Chem.
doi: 10.1016/s0005-2728(98)00161-3 2019;7:775.
265. Huang Y, Sun G, Sun X, et al. The potential of lonidamine doi: 10.3389/fchem.2019.00775
in combination with chemotherapy and physical therapy in
cancer treatment. Cancers (Basel). 2020;12(11):3332. 276. Cheng G, Zielonka J, Ouari O, et al. Mitochondria-targeted
analogues of metformin exhibit enhanced antiproliferative
doi: 10.3390/cancers12113332 and radiosensitizing effects in pancreatic cancer cells.
266. Yang SK, Han YC, He JR, et al. Mitochondria targeted Cancer Res. 2016;76(13):3904-3915.
peptide SS-31 prevent on cisplatin-induced acute kidney doi: 10.1158/0008-5472.can-15-2534
injury via regulating mitochondrial ROS-NLRP3 pathway. 277. Smith RA, Porteous CM, Gane AM, Murphy MP. Delivery
Biomed Pharmacother. 2020;130:110521.
of bioactive molecules to mitochondria in vivo. Proc Natl
doi: 10.1016/j.biopha.2020.110521 Acad Sci U S A. 2003;100(9):5407-5412.
267. Cheng G, Zhang Q, Pan J, et al. Targeting lonidamine to doi: 10.1073/pnas.0931245100
mitochondria mitigates lung tumorigenesis and brain 278. Zielonka J, Joseph J, Sikora A, et al. Mitochondria-targeted
metastasis. Nat Commun. 2019;10(1):2205.
triphenylphosphonium-based compounds: Syntheses,
doi: 10.1038/s41467-019-10042-1 mechanisms of action, and therapeutic and diagnostic

Volume 7 Issue 2 (2024) 25 doi: 10.36922/itps.1726